Veterinary Molecular Diagnostics Market Reaches US$ 284.7 Million by 2030, Growing at 6.4% CAGR, Reveals RationalStat Ma

Comments · 18 Views

The global veterinary molecular diagnostics market is expected to reach US$ 284.7 million by 2030, with an annual growth rate of more than 6.4%.
According to RationalStat’s recent industry analysis, the Global Veterinary Molecular Diagnostics Market value is estimated at US$ 184.4 m

Market Definition, Market Scope, and Report Overview                                                           

Veterinary molecular diagnostics refers to the use of molecular biology techniques to identify and analyze genetic material (DNA or RNA) in animals for diagnostic purposes. This field involves the application of advanced molecular tools to detect and characterize various infectious diseases, genetic disorders, and other health-related conditions in animals.

The rising trend of pet ownership globally has led to increased spending on veterinary care. Pet owners are increasingly seeking advanced diagnostic services, including molecular diagnostics, to ensure the health and well-being of their pets.

According to a deep-dive market assessment by RationalStat, the global veterinary molecular diagnostics market has been analyzed on the basis of market segments, including products, technology, animal type, end user, and geography/regions (including North America, Latin America, Western Europe, Eastern Europe, Middle East Africa, and Asia Pacific). The report also offers global and regional market sizing for the historical period of 2019-2022 and the forecast period of 2023-2030.

  • Market intelligence for the global veterinary molecular diagnostics market covers market sizes on the basis of market value (US$/EUR Million), volume (Units) by various products/services/equipment, demand assessment across the key regions, customer sentiments, price points, cost structures, margin analysis across the value chain, financial assessments, historical and forecast data, key developments across the industry, import-export data, trade overview, components market by leading companies, etc.
  • In addition, the long-term sector and products/services 10-year outlook and its implications on the global veterinary molecular diagnostics It also includes the industry's current state – Production levels, Capacity Utilization, Tech quotient, etc. Key information will be manufacturing capacity by country, installed base, import volumes, market size, key players, market size, dynamics, market data, insights, etc.

Request A Customization- https://store.rationalstat.com/store/global-veterinary-molecular-diagnostics-market/

Global Veterinary Molecular Diagnostics Market: Segmental and Market Share Analysis

  • On the basis of animal type, companion animals segment held the largest market share of 62% in 2022 attributed to factors such as rising adoption of companion animals like dogs and cats.

Report Synopsis

Report Metrics

Details

Base Year

2023

Forecast Period

2023-2030

Base Year Market Size

US$ 184.4 million

Market Size Forecast

US$ 284.7 million

Growth Rate

6.4%

Dominant Segment

Companion Animals

Dominant Region

North America  

Key Market Drivers

·        Growing prevalence of animal diseases

·        Increasing prevalence of pet adoption

Companies Profiled

  • IDEXX Laboratories Inc
  • Zoetis Inc
  • Thermo Fisher Scientific Inc
  • bioMerieux
  • Heska Corporation
  • NEOGEN Corporation
  • Bio-Rad Laboratories
  • Virbac
  • FUJIFILM Holdings Corporation
  • Shenzhen Mindray Animal Medical Technology Co. Ltd,
  • INDICAL BIOSCIENCE GmbH
  • BioChek
  • IDvet

 

Explore more about this report- https://store.rationalstat.com/store/global-veterinary-molecular-diagnostics-market/

Competition Analysis and Market Structure

Some leading players adopt various strategies in order to reinforce their market share and gain a competitive edge over other competitors in the market. Mergers and acquisitions, partnerships and collaborations, and product launches are some of the strategies followed by industry players. 

  • In June 2022: AusDiagnostics acquired by R-Biopharm AG. R-Biopharm increased its product line with molecular biology multiplex diagnostics, extraction reagents, and laboratory automation equipment for animals and humans as a result of this acquisition.

Some of the prominent players and suppliers operating and contributing significantly to the global veterinary molecular diagnostics market growth include IDEXX Laboratories Inc, Zoetis Inc, Thermo Fisher Scientific Inc, bioMerieux, Heska Corporation, NEOGEN Corporation, Bio-Rad Laboratories, Virbac, FUJIFILM Holdings Corporation, Shenzhen Mindray Animal Medical Technology Co. Ltd, INDICAL BIOSCIENCE GmbH, BioChek, and IDvet, among others.

Get A Free Sample- https://store.rationalstat.com/store/global-veterinary-molecular-diagnostics-market/

Read more
Comments